Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

A crucial link between the brain's cleaning system and deterioration of neurons associated with Alzheimer's disease has been ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is a biopharmaceutical company that identifies, develops, and delivers therapies to ...

A crucial link between the brain's cleaning system and deterioration of neurons associated with Alzheimer's disease has been ...

DataM Intelligence | competitive Intelligence GA treatment market heats up: Syfovre & Izervay lead, while oral, gene, cell therapies and AI ...

Ocutrx Technologies Inc. ("Ocutrx"), through its R&D division Genius Labs, today unveiled a major surgical innovation: the ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein ...